US2014017784A1PendingUtilityA1

Methods for Expansion and Analysis of Cultured Hematopoietic Stem Cells

Assignee: WHITEHEAD BIOMEDICAL INSTPriority: May 24, 2005Filed: Jul 12, 2013Published: Jan 16, 2014
Est. expiryMay 24, 2025(expired)· nominal 20-yr term from priority
C12N 5/00C12N 2501/145A61P 37/04C12N 2501/113C12N 2501/17A61P 7/04A61P 7/00A61P 7/06C12N 2501/105C12N 2500/90A61P 31/18A61P 31/04C12N 5/0647C12N 2501/125A61K 2035/124C12N 2501/91
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods and kits for propagating hematopoietic stem cells are provided. The methods comprise culturing cells in medium comprising one or more angiopoietin-like proteins, under conditions sufficient for expansion of HSCs. Angiopoietin-like proteins include angiopoietin-like protein 2, angiopoietin-like protein 3, angiopoietin-like protein 4, angiopoietin-like protein 5, angiopoietin-like protein 7, and microfibrillar-associated glycoprotein (Mfap4). Methods for identifying hematopoietic stem cells are provided and isolated hematopoietic stem cells are also provided.

Claims

exact text as granted — not AI-modified
1 - 38 . (canceled) 
     
     
         39 . A kit for propagating hematopoietic stem cells (HSCs) in vitro comprising:
 a) medium suitable for culturing one or more cells comprising an HSC,   b) at least one angiopoietin-like protein, and   c) at least one additional growth factor selected from the group consisting of insulin-like growth factor (IGF), fibroblast growth factor (FGF), thrombopoietin (TPO), and stem cell factor (SCF).   
     
     
         40 - 46 . (canceled) 
     
     
         47 . The kit of  claim 39 , wherein the angiopoietin-like protein is selected from the group consisting of angiopoietin-like protein 2, angiopoietin-like protein 3, angiopoietin-like protein 4, angiopoietin-like protein 5, angiopoietin-like protein 7, and Mfap4. 
     
     
         48 . The kit of  claim 39 , wherein when in use, the angiopoietin-like protein is present in the medium at a concentration of about 0.1 ng/mL to about 500 ng/mL. 
     
     
         49 . The kit of  claim 39 , wherein the angiopoietin-like protein is a recombinant protein. 
     
     
         50 . The kit of  claim 39 , wherein the kit comprises SCF. 
     
     
         51 . The kit of  claim 39 , wherein when in use, the additional growth factor is present in the medium at a concentration of about 0.1 ng/mL to about 500 ng/mL. 
     
     
         52 . The kit of  claim 39 , wherein the one or more cells are selected from the group consisting of bone marrow cells, umbilical cord blood cells, and fetal liver cells. 
     
     
         53 . The kit of  claim 39 , wherein the one or more cells are human cells. 
     
     
         54 . The kit of  claim 39 , wherein the one or more cells are primary cells. 
     
     
         55 . The kit of  claim 39 , further comprising an instruction to culture the one or more cells for at least five days. 
     
     
         56 . A kit for propagating hematopoietic stem cells (HSCs) in vitro comprising:
 a) medium suitable for culturing primary cells comprising an HSC;   b) at least one angiopoietin-like protein selected from the group consisting of angiopoietin-like protein 2, angiopoietin-like protein 3, angiopoietin-like protein 4, angiopoietin-like protein 5, angiopoietin-like protein 7, and Mfap4; and   c) at least one additional growth factor selected from the group consisting of insulin-like growth factor (IGF), fibroblast growth factor (FGF), thrombopoietin (TPO), and stem cell factor (SCF).   
     
     
         57 . The kit of  claim 56 , wherein when in use, the angiopoietin-like protein is present in the medium at a concentration of about 0.1 ng/mL to about 500 ng/mL 
     
     
         58 . The kit of  claim 56 , wherein the angiopoietin-like protein is a recombinant protein. 
     
     
         59 . The kit of  claim 56 , wherein the kit comprises SCF. 
     
     
         60 . The kit of  claim 56 , wherein when in use, the additional growth factor is present in the medium at a concentration of about 0.1 ng/mL to about 500 ng/mL 
     
     
         61 . The kit of  claim 56 , wherein the primary cells are selected from the group consisting of bone marrow cells, umbilical cord blood cells, and fetal liver cells. 
     
     
         62 . The kit of  claim 56 , wherein the primary cells are human cells. 
     
     
         63 . The kit of  claim 56 , further comprising an instruction to culture the one or more cells for at least five days. 
     
     
         64 . A method of propagating hematopoietic stem cells (HSCs) in vitro comprising:
 (a) providing the kit of  claim 39 ; and   (b) culturing the one or more cells in the medium comprising the angiopoietin-like protein and the additional growth factor.   
     
     
         65 . A method of propagating hematopoietic stem cells (HSCs) in vitro comprising:
 (a) providing the kit of  claim 56 ; and   (b) culturing the primary cells in the medium comprising the angiopoietin-like protein and the additional growth factor.

Join the waitlist — get patent alerts

Track US2014017784A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.